Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for JNJ
Company Monitoring Page for JNJ
latest headlines for company on cafepharma
Johnson & Johnson Bets on Nurses in Push to Develop Innovative Medical Devices
Xtalks
Tue, 10/2/18 - 10:07 am
Tags:
JNJ
,
devices
,
JLabs
,
nurses
,
innovation
Can Geron Corporation Recover From Its Breakup With Johnson & Johnson?
Motley Fool
Sat, 09/29/18 - 12:04 am
Tags:
Geron
,
JNJ
J&J inks collab deal to develop MERS vaccine
Drug Delivery Business News
Thu, 09/27/18 - 10:58 pm
Tags:
JNJ
,
MERS
,
vaccines
J&J has decided — pharma giant dumps its development deal on Geron’s imetelstat, shattering shares
Endpoints
Thu, 09/27/18 - 10:02 am
Tags:
JNJ
,
Geron
,
imetelstat
J&J's Esketamine Fails to Meet Endpoint in Phase III Study
Yahoo/Zacks.com
Tue, 09/25/18 - 09:45 am
Tags:
JNJ
,
clinical trials
,
esketamine
,
treatment-resistant depression
Boston Scientific, Edwards Lifesciences May Tempt J&J
Barrons
Sat, 09/22/18 - 05:21 pm
Tags:
devices
,
JNJ
,
Boston Scientific
,
Edwards Lifesciences
Pfizer, Merck and Johnson & Johnson shifting profits to avoid billions in tax payments each year: report
Fierce Pharma
Thu, 09/20/18 - 12:06 pm
Tags:
taxes
,
Pfizer
,
Merck
,
JNJ
,
Abbott Labs
J&J Files NDA for Erdafitinib in Urothelial Cancer Indication
Yahoo/Zacks.com
Wed, 09/19/18 - 11:52 am
Tags:
JNJ
,
erdafitinib
,
urothelial cancer
Pharma/Biotech Stocks to Watch This Prostate Cancer Month
Yahoo/Zacks.com
Sun, 09/16/18 - 02:16 pm
Tags:
prostate cancer
,
JNJ
,
Zytiga
,
Erleada
,
Pfizer
,
Astellas
,
Xtandi
,
AbbVie
,
Lupron
,
Endocyte
,
Lu-PSMA-617
J&J execs say new launches and label expansions will fuel 'above-market' growth through 2021
Fierce Pharma
Fri, 09/14/18 - 09:52 am
Tags:
JNJ
,
label expansions
,
esketamine
,
erdafitinib
Johnson & Johnson Seeks EU and US Label Expansion for Darzalex
Market Realist
Thu, 09/13/18 - 11:34 am
Tags:
JNJ
,
Janssen
,
Darzalex
,
daratumumab
,
Europe
,
Multiple Myeloma
J&J acquires 3D-printed spinal implant maker EIT
Mass Device
Wed, 09/12/18 - 11:25 am
Tags:
JNJ
,
devices
,
spinal fusion
,
Emerging Implant Technologies
,
EIT
,
M&A
Johnson & Johnson raises a flag in early-stage lung cancer with first-ever contest in the field
Fierce Pharma
Wed, 09/12/18 - 11:12 am
Tags:
JNJ
,
innovation
,
R&D
,
lung cancer
,
drug development
Ph III Trial Shows Improved Outcomes with Tremfya after Failure With Humira
CP Wire
Wed, 09/12/18 - 11:08 am
Tags:
Janssen Pharmaceuticals
,
JNJ
,
chronic plaque psoriasis
,
Tremfya
,
Humira
,
AbbVie
,
clinical trials
Wed, 09/12/18 - 09:14 am
Tags:
Janssen Pharmaceuticals
,
JNJ
,
chronic plaque psoriasis
,
Tremfya
,
Humira
India Orders Payments From J&J’s DePuy Over ‘Faulty’ Hip Implants
RAPS.org
Thu, 09/6/18 - 11:12 pm
Tags:
India
,
DePuy
,
JNJ
,
hip implants
Amarin Corporation, CRISPR Therapeutics, and Geron Corporation could all see big gains next week
Motley Fool
Mon, 09/3/18 - 12:20 pm
Tags:
Amarin
,
CRISPR Therapeutics
,
Geron
,
Vascepa
,
Vertex Pharmaceuticals
,
CTX001
,
JNJ
,
imetelstat
Ketamine is emerging as a popular treatment for depression. New research suggests the drug acts like an opioid
CNBC
Wed, 08/29/18 - 10:31 am
Tags:
depression
,
ketamine
,
opioids
,
JNJ
,
Allergan
ESC 2018 – J&J not downhearted after Xarelto stumbles
EP Vantage
Tue, 08/28/18 - 07:57 pm
Tags:
ESC 2018
,
JNJ
,
Xarelto
,
bloodthinner
Johnson & Johnson Is Hiring -- and It's Ginormous News for Geron
Yahoo/Motley Fool
Tue, 08/28/18 - 10:06 am
Tags:
JNJ
,
Geron
,
hirings
,
imetelstat
,
Imbruvica
Pages
« first
‹ previous
…
57
58
59
60
61
62
63
64
65
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.